The Pharmaceutical Market: China27 Oct 2010 • by Natalie Aster
The present report provides in-depth information, setting the pharmaceutical market in context. A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
Published: September 2010
Price: US$ 1,040.00
Report Sample Abstract
China ranks as the largest economic power of the Asia Pacific region and the second largest of the world, behind only the USA, with a projected GDP of US$5.6 trillion in 2010. In terms of GDP per capita, this is considerably lower owing to the large population, at US$4,170 in 2010. This is slightly higher than that of Thailand. China has been largely unaffected by the economic slowdown, with GDP growth never falling below 8.2%. The EIU estimates GDP in China to be US$11.8 trillion in 2015, about twice the size of the Japan.
China is likely to have improved relations with not only Taiwan but also Japan in the forecast period, which can be attributed to new leadership in both countries. This will prove beneficial to the Chinese economy, as these two countries are major economies not only in the Asia Pacific region, but also in the world. The fact that China has been largely unaffected by the current economic slowdown, despite it being a large exporting economy, can be attributed to its decision to invest heavily in infrastructure throughout 2009, thus creating jobs which may otherwise have been lost. China’s exports will resume to the amount experienced before the current situation by 2011, and with growth expected in 2010 also.
More details on the research report can be found at https://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/pharmaceutical_market_china.html
To order the report or ask for free sample pages contact email@example.com
Mrs. Alla Martin
Tel: +44 208 123 2220
Fax: +44 207 900 3970